A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
This study will assess the serum uric acid lowering effects and safety of lesinurad in combination with allopurinol over a long-term timeframe.
This is a Phase 3 extension study to assess the long-term efficacy and safety of lesinurad in combination with allopurinol in subjects who completed the double-blind treatment period in Studies RDEA594-301 and RDEA594-302.
Inclusion Criteria:
Exclusion Criteria:
Colombus, Ohio 43235, United States
Birkinhead, 0626, New Zealand
Warminsko-mazurskie, 82-300, Poland
Silverglen, Durban 4092, South Africa
Sowento, Johannesburg 1804, South Africa
Muckleneuk, Pretoria 0002, South Africa